Option Care Health Q2 revenue beats estimates

Overview

• US home infusion provider's Q2 revenue rose 1.9%, beating analyst expectations

• Adjusted EPS and adjusted EBITDA for Q2 beat analyst expectations

• Company repurchased $150 mln of shares during the quarter

Outlook

• Option Care Health sees full-year net revenue of $5.675 bln to $5.775 bln

• Company expects full-year adjusted diluted EPS of $1.85 to $1.92

• Option Care Health expects Q3 sequential net revenue growth in low to mid single-digits

Result Drivers

• STRATEGIC INITIATIVES - Co said Q2 results reflected positive impact of 2026 strategic initiatives

• OPERATIONAL EXECUTION - Co attributed Q2 performance to solid operational execution, per CEO John C. Rademacher

Company press release: ID:nGNX1xcy4q

Key Details

Reuters Recommended Reads

• July 28 - Chemed Q2 revenue beats estimates, helped by VITAS segment growth

• July 29 - Humana beats earnings estimates, maintains 2026 adjusted profit forecast

• July 28 - Acadia Healthcare Q2 revenue beats in inpatient growth but costs bite

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)